Califia Farms Completes Landmark $225 Million Financing with D... - 15 January 2020 21:00

LOS ANGELES, Jan. 15, 2020 /PRNewswire-AsiaNet/ -- -- Funding Provides Califia Farms, a leading plant-based food and beverage company, with long-term capital and global support for continued rapid expansion, and disruption of the $1 trillion+ dairy and ready-to-drink coffee markets Califia Far...

  ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into ... - 14 January 2020 17:00

TOKYO, Jan. 14, 2020 /Kyodo JBN-AsiaNet/ -- ASKA Pharmaceutical Co., Ltd. (hereinafter "ASKA") and KinoPharma, Inc. (hereinafter "KinoPharma"), both based in Tokyo, announced on January 14 that they have entered into an option agreement for an exclusive license for the development and comme...

  Genome & Company announces a clinical trial collaboration and ... - 14 January 2020 11:00

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire-AsiaNet/ -- -- Clinical partnership of phase 1/1b combination clinical trial with Genome & Company's GEN-001, microbiome-based immuno-oncology therapy, and avelumab (BAVENCIO®), Merck KGaA, Darmstadt, Germany and Pfizer Inc.'s anti-PD-L1 antibody in oncology ...

  COMPASS Pathways Granted Patent Covering Use of Its Psilocybin... - 13 January 2020 22:33

LONDON, January 13, 2020 /PRNewswire-AsiaNet/-- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The p...

  Exonate Announces Collaboration With Janssen to Develop a New ... - 13 January 2020 19:00

CAMBRIDGE, England, Jan. 13, 2020/PRNewswire-AsiaNet/-- The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss. Exonate, an early stage biotechnology ...

  Publication of a Toxicological Study: A Milestone for Jennewei... - 10 January 2020 20:52

RHEINBREITBACH, Germany, Jan. 10, 2020 /PRNewswire-AsiaNet/ -- Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the "HMO-Mix." The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats," was r...

  Dr. Mark Bittinger Joins Sai Life Sciences as Global Head of B... - 10 January 2020 18:01

HYDERABAD, India, Jan. 10, 2020 /PRNewswire-AsiaNet/-- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Dr. Mark Bittinger as Vice President and Global Head of Biology. Mark will be based out of the com...

  Alma, a Sisram Medical Company, Receives Excellence Award for ... - 09 January 2020 13:00

NURNBERG, Germany, January 9, 2020, /PRNewswire-AsiaNet/-- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance in Japan" in 2019. The annual “Excellence Award...

  Former Celgene Chairman and CEO Mark J. Alles Joins Antengene ... - 08 January 2020 23:07

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire-AsiaNet/ -- The Antengene board today announced the appointment of Mr. Mark J. Alles as an independent director of the company, effective January 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiary of...

  Inovio Provides Update on Clinical Program Plans for 2020 - 07 January 2020 00:00

PLYMOUTH MEETING, Pennsylvania., Jan. 6, 2020 /PRNewswire-AsiaNet/ -- -- Inovio to present 2020 program plans at Biotech Showcase 2020 Conference Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical progra...